(Reuters) – Omeros Corp on Monday reported positive results from a six-patient study of its investigational treatment for Acute Respiratory Distress Syndrome caused by COVID-19.
The company said all the six patients, who needed mechanical ventilation before treatment, recovered and were discharged from hospital.
A manuscript detailing the results of the study has been accepted for publication in the peer-reviewed journal Immunobiology, Omeros said.
Shares of the company soared 44% to $20.25 in premarket trading.
(Reporting by Vishwadha Chander in Bengaluru; Editing by Arun Koyyur)
